Automate Your Wheel Strategy on POM
With Tiblio's Option Bot, you can configure your own wheel strategy including POM - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowNews
Bronstein, Gewirtz & Grossman LLC Urges PomDoctor, Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
Published: February 09, 2026 by: GlobeNewsWire
Sentiment: Neutral
New class action for PomDoctor (POM) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 4/6/2026.
Read More
Scott+Scott Attorneys at Law LLP Files Securities Class Action Against PomDoctor, Ltd. (NASDAQ: POM)
Published: February 06, 2026 by: Business Wire
Sentiment: Neutral
NEW YORK--(BUSINESS WIRE)---- $POM #POM--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, today announced that it has filed a class action lawsuit against Defendants PomDoctor Ltd., Zhenyang Shi, Li Xu, Cogency Global, Joseph Stone Capital, LLC, and Marcum Asia CPAs, LLP (collectively, the “Defendants”). The action, which was filed in the U.S. District Court for the Southern District of New York and captioned Louie v. PomDoctor Ltd. et al., Ca.
Read More
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of POMDOCTOR LIMITED (POM) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm
Published: February 06, 2026 by: GlobeNewsWire
Sentiment: Neutral
ATLANTA, Feb. 06, 2026 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against POMDOCTOR LIMITED (“Pomdoctor” or the “Company”) (NASDAQ: POM). The lawsuit alleges that Defendants issued false and misleading statements and/or failed to disclose material adverse facts, including allegations that: (i) Pomdoctor was the subject of a fraudulent stock promotion scheme involving social media-based misinformation and impersonated financial professionals; (ii) insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign; and (iii) Pomdoctor's public statements and risk disclosures omitted any mention of the false rumors and …
Read More
POMDOCTOR LIMITED Drive Internet Hospital Growth Through Strengthened Strategic Partnerships With Pharmaceutical Companies
Published: January 16, 2026 by: PRNewsWire
Sentiment: Neutral
GUANGZHOU, China, Jan. 16, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, today announced significant progress in its strategic collaboration with leading domestic pharmaceutical companies to accelerate the growth of its internet hospital business. The Company expects these partnerships to become a core component of its long-term strategy to expand online hospital operations and enhance overall profitability.
Read More
About POMDOCTOR Ltd (POM)
- IPO Date 2025-10-08
- Website https://www.7lk.com
- Industry Medical - Pharmaceuticals
- CEO Zhenyang Shi
- Employees 156